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Abstract
Erythrocyte invasion by Plasmodium falciparum is central to the pathogenesis of malaria. Invasion 
requires a series of extracellular recognition events between erythrocyte receptors and ligands on 
the merozoite, the invasive form of the parasite. None of the few known receptor-ligand 
interactions involved1-4 are required in all parasite strains suggesting that the parasite is able to 
access multiple redundant invasion pathways5. Here, we show that we have identified a receptor-
ligand pair that is essential for erythrocyte invasion in all tested P. falciparum strains. By 
systematically screening a library of erythrocyte proteins, we have found that the Ok blood group 
antigen, BASIGIN, is a receptor for PfRh5, a parasite ligand that is essential for blood stage 
growth6. Erythrocyte invasion was potently inhibited by soluble BASIGIN or by BASIGIN 
knockdown, and invasion could be completely blocked using low concentrations of anti-BASIGIN 
antibodies; importantly, these effects were observed across all laboratory-adapted and field strains 
tested. Furthermore, Ok(a−) erythrocytes, which express a BASIGIN variant that has a weaker 
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binding affinity for PfRh5, exhibited reduced invasion efficiencies. Our discovery of a cross-strain 
dependency on a single extracellular receptor-ligand pair for erythrocyte invasion by P. 
falciparum provides a focus for novel anti-malarial therapies.
Amongst the many P. falciparum merozoite proteins that are believed to have a role in 
erythrocyte invasion, most attention has focussed on two major parasite protein families: the 
EBAs and Rhs7. Although erythrocyte receptors have been identified for some of them 
(members of the glycophorin family are receptors for three EBAs1-3and Complement 
receptor 1 (CD35) has recently been identified as a receptor for PfRh44) none of these 
receptor-ligand pairs are essential in all parasite strains tested. PfRh5 is unique amongst the 
EBAs and Rhs because it cannot be deleted in any P. falciparum strain and is therefore 
apparently essential for parasite growth in blood stage culture5,6. Both native and 
recombinant PfRh5 have been previously shown to bind erythrocytes through an unknown 
glycosylated receptor that is resistant to chymotrypsin, trypsin and neuraminidase 
treatment6,8,9.
To identify an erythrocyte receptor for PfRh5, we employed a systematic screening 
approach by first compiling a library of abundant cell surface and secreted proteins 
expressed by human erythrocytes based on published proteomics data10. Proteins for which 
the entire ectodomain was expected to be expressed as a soluble recombinant protein were 
selected (Supplementary Table 1), and expressed by mammalian cells (Supplementary Fig. 
1). The 40 proteins within the erythrocyte ectodomain protein library were then 
systematically screened using the AVEXIS assay11 for interactions with a recombinant 
PfRh5 protein, also produced by mammalian cells. The AVEXIS assay (AVidity-based 
EXtracellular Interaction Screen) is designed to detect direct low affinity protein interactions 
between ectodomain fragments expressed as either biotin-tagged baits or highly avid 
pentameric ß-lactamase-tagged preys12,13. The PfRh5 prey interacted with a single 
erythrocyte receptor bait (Fig. 1a, top panel) corresponding to the Ok blood group antigen, 
BASIGIN (BSG, also known as CD147, EMMPRIN and M614). The same single interaction 
was identified in the reciprocal bait-prey orientation (Fig. 1a, lower panel).
BSG is a member of the immunoglobulin superfamily (IgSF) and has been implicated in 
many biological functions including embryo implantation, spermatogenesis15 and retinal 
development16. BSG exists in both long (three IgSF domains, BSG-L) and short (two IgSF 
domains, BSG-S) splice isoforms (Fig. 1b) and although BSG-L was used in the screen, 
BSG-S is thought to be the major isoform expressed on erythrocytes. Binding experiments 
using domain deletions established that PfRh5 could interact with BSG-S and this required 
both domains since neither of the two BSG-S IgSF domains were individually able to bind 
PfRh5 (Fig. 1b, Supplementary Fig. 2). We showed that PfRh5 directly interacted with 
BSG-S and BSG-L using purified proteins and surface plasmon resonance (SPR). Both 
kinetic (Fig. 1c) and equilibrium (Supplementary Fig. 3) binding parameters for the 
interaction were derived using a 1:1 binding model and were in excellent agreement 
(Supplementary Table 2). These parameters are typical of extracellular protein interactions 
measured using this technique17. Removal of glycans from BSG either by mutating all 
predicted glycosylation motifs or by enzymatic treatment did not affect PfRh5 binding 
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(Supplementary Fig. 4), suggesting the PfRh5 binding site is solely located in the BSG 
protein core. BSG is also known to be resistant to trypsin and chymotrypsin treatment18 
consistent with previous PfRh5-erythocyte binding studies6,8,9.
To determine whether the PfRh5-BSG interaction was required for invasion, we added 
purified pentamerised soluble BSG-S into invasion assays to specifically compete with the 
membrane-bound receptor. We found that BSG-S strongly inhibited invasion in a dose-
dependent manner relative to controls which included each of the two non-binding BSG-S 
IgSF domains added individually (Fig. 2a). Strong inhibition was also observed across 
multiple strains (Fig. 2b) or when soluble BSG-L was added (Supplementary Fig. 5) 
although this was slightly weaker for the 3D7 strain. Soluble forms of BSG consisting of the 
extracellular regions are known to have biological effects such as upregulation of matrix 
metalloproteases19. To rule out an indirect effect of exogenous BSG on invasion, we added 
to invasion assays two independent purified anti-BSG monoclonal antibodies (MEM-M6/6 
and TRA-1-85) which could both block the PfRh5-BSG interaction in vitro (data not 
shown). These high affinity reagents gave a potent invasion blocking effect that was 
saturable at very low antibody concentrations (IC50 ~ 0.5 μg/ml), consistent with binding 
and occluding a specific surface receptor of typical abundance (~104 to 106 molecules per 
cell20) (Fig. 2c). Preadsorbtion of the MEM-M6/6 antibody with soluble monomeric BSG 
specifically relieved the inhibition, ruling out any indirect effect of the antibody on non-
BSG targets; furthermore, MEM-M6/6 did not affect intra-erythrocytic P. falciparum 
development (Supplementary Fig. 6). Invasion was quantified using flow cytometry and a 
fluorescent DNA dye to stain parasites21. Using this assay, apparent invasion could not be 
eliminated, with efficiencies reduced to a maximum of 80-90%, even at much higher 
concentrations of antibody (up to 1.5 mg/ml of MEM-M6/6 – data not shown); however, 
direct observation of parasites using Giemsa-stained thin smears revealed that this residual 
staining in cytometry assays was due to extracellular parasites and debris in the culture. 
Using microscopy-based assays, we found that MEM-M6/6 concentrations of 10 μg/ml or 
more was sufficient to prevent all detectable invasion (Fig. 2d).
P. falciparum isolates can vary widely in their ability to invade erythrocytes treated with 
different receptor-modifying enzymes such as trypsin, chymotrypsin and neuraminidase, 
revealing differential dependencies on erythrocyte receptors for invasion. To determine if 
BSG was a critical invasion receptor across P. falciparum lines that use different invasion 
pathways, we tested the ability of MEM-M6/6 to block erythrocyte invasion on nine culture-
adapted strains representing seven different PfRh5 sequence variants (Supplementary Table 
3). We observed that the invasion of all lines was potently inhibited by MEM-M6/6 (Fig. 
2e). To show that the dependency on BSG was not an unusual feature of culture-adapted 
lines, we also tested six freshly-isolated P. falciparum strains from Senegal22 and again 
observed a potent inhibitory effect (Fig. 2f). Assays with the field isolates were carried out 
with unsynchronised parasites, decreasing the overall inhibitory effect because not all 
parasites had reinvaded over the course of the assay. All six Senegal isolates, however, were 
inhibited by MEM-M6/6 to the same extent as an unsynchronised culture-adapted line, 
W2mef, tested at the same time. This demonstrated that freshly-isolated field strains have 
the same dependency on BSG as laboratory-adapted lines (Fig. 2f).
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To independently confirm the essentiality of BSG as a P. falciparum invasion receptor, we 
used a genetic approach by differentiating erythrocytes from hematopoietic stem cells 
transduced with lentiviruses containing either an shRNA targeting BSG or a scrambled 
shRNA control (pLKO). BSG-targeted erythrocytes showed a reproducible knockdown to 
approximately 50 to 60% of cell surface BSG levels relative to the pLKO control (Fig. 2g) 
and expressed markers indicative of complete erythrocyte maturation (Supplementary Fig. 
7). The invasion of both the 3D7 and W2mef P. falciparum strains into BSG-knockdown 
erythrocytes was significantly reduced compared to the control (18% versus 94% for 3D7 
and 14% versus 103% for W2mef, Fig. 2h). By contrast, previous knockdown of GYPA, the 
major surface sialoglycoprotein, significantly inhibited the W2mef but not the 3D7 strain23. 
The inhibition of erythrocyte invasion by multiple P. falciparum strains using soluble BSG, 
anti-BSG monoclonal antibodies, or knockdown of BSG surface expression suggests that 
BSG is a critical host receptor for P. falciparum invasion.
Malaria is thought to have been a strong selective pressure in human evolutionary history 
and given the apparently essential roles of PfRh5 and BSG in P. falciparum invasion we 
sought to determine if any human populations contained genetic variants in BSG that might 
affect PfRh5 binding and invasion. Five nonsynonymous single nucleotide polymorphisms 
(SNPs) have been described within the BSG-S IgSF domains (Supplementary Table 4, Fig. 
3a). These variants were expressed and the biophysical PfRh5 binding parameters 
determined using SPR. Equilibrium measurements showed that two variants had lower 
binding affinity compared to the BSG reference sequence: L90P and E92K (Fig. 3b, 
Supplementary Table 2). L90P did not interact with PfRh5 and binding profiles of several 
anti-BSG monoclonal antibodies suggested local misfolding of the membrane-distal IgSF 
domain (Supplementary Fig. 8). No verification or population frequency data for this SNP 
are currently available preventing further biological interpretation of this variant. E92K had 
a two-fold lower affinity for PfRh5 (Fig. 3b) and a comparative kinetic analysis 
demonstrated that this was due to both a slower association and a faster dissociation rate 
(Fig. 3c, Supplementary Table 2). The E92 residue is solvent exposed and located within the 
loop connecting the F-G ß-strands close to the glycan-free GFC ß-sheet, consistent with a 
possible PfRh5 binding interface (Fig. 3a). E92K is the variant responsible for the Ok(a−) 
blood group, which has been described in eight Japanese families14. Ok(a−) erythrocytes 
from two unrelated donors showed reduced invasion with both 3D7 and Dd2 P. falciparum 
strains relative to Ok(a+) controls (Fig. 3d, Supplementary Fig. 9), correlating with the 
reduced affinity of the Ok(a−) variant for PfRh5. The extreme rarity and restriction of the 
Ok(a−) blood group to Japanese individuals suggest that this specific allele has not played a 
major role in conferring resistance to malaria. It is possible that other BSG polymorphisms, 
as yet unknown, have evolved in some malaria-exposed populations as a mechanism of 
resistance to P. falciparum. The search for functional polymorphisms of BSG needs to go 
beyond gene coding regions as the results of our knockdown experiments suggest that 
expression levels of BSG at the erythrocyte surface influence the ability of the parasite to 
invade. The Duffy variant which confers resistance to P. vivax is also a non-coding 
regulatory polymorphism that suppresses expression of the invasion receptor by 
erythrocytes. Our ability to address this problem is currently limited by the lack of data on 
genome variation among the many different ethnic groups that are exposed to P. falciparum 
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malaria, but will be greatly enhanced by the 1000 Genomes Project, MalariaGEN and other 
genetic studies that are now in progress in Africa and other malaria-endemic regions of the 
world24-26. Inter-population comparisons of haplotype length and frequency provide a 
potentially powerful way of addressing this problem27, and there is preliminary evidence 
that a region of chromosome 19 encompassing BSG and several neighbouring genes has 
undergone recent positive selection in West Africa, but a considerable amount of further 
work is needed to determine whether this is causally related to the role of BSG as a malaria 
invasion receptor (MalariaGEN consortium, unpublished data).
In summary, we have applied a systematic protein interaction screening approach (AVEXIS) 
to identify BSG as an erythrocyte receptor for PfRh5. Importantly, we were able to prevent 
all detectable erythrocyte invasion by every P. falciparum strain that we tested using only 
modest concentrations of anti-BSG antibodies. These observations, coupled with the 
inability to delete PfRh56, lead us to conclude that the interaction between BSG and PfRh5 
is essential for parasite entry, and may perform a fundamentally different function to the 
other EBA and Rh proteins, which are involved in redundant, partially overlapping invasion 
pathways. The dependence on a single receptor-ligand pair across many P. falciparum 
strains may provide new possibilities for therapeutic intervention.
Methods summary
Recombinant protein production and interaction screening
Protein production, purification, AVEXIS assays and SPR were performed essentially as 
described11 except the type II proteins which were expressed with an N-terminal Cd4d3+4-
biotin tag and a mouse antibody signal peptide. PfRh5 was expressed as above except that a 
non-endogenous signal peptide was added and the threonines in potential N-linked glycan 
sequons were mutated to alanine to prevent inappropriate glycosylation. All constructs were 
chemically synthesized and codon optimised for mammalian expression (Geneart AG). 
Purified pentameric proteins used in invasion assays were made by replacing the β-
lactamase reporter in the prey plasmid with a hexa-his tag, purified and buffer exchanged 
into RPMI prior to use. BSG variants were produced by site directed mutagenesis.
P. falciparum culture, lentiviral transduction and invasion assays
P. falciparum parasite strains were routinely cultured in human O+ erythrocytes at 5% 
hematocrit. Use of erythrocytes from human donors for P. falciparum culture was approved 
by the NHS Cambridgeshire 4 Research Ethics Committee. Ok(a−) and control Ok(a+) blood 
was obtained from donors in Japan with informed consent, shipped on ice and experiments 
performed within 72 hours. Invasion assays were carried out as described previously21 using 
the two-colour assay for the Ok(a−) experiment. Lentiviral transduction of HSCs was 
performed as previously described23.
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Proteins selected for expression included all type I, type II, GPI-linked receptors and 
secreted proteins. Some multipass transmembrane proteins were also included where there 
was an extracellular N-terminus preceded by a signal peptide (Supplementary Table 1). 
Individual domains of human BSG were produced by identifying domain boundaries using 
the structure of the BSG extracellular region28,29 and amplifying these regions using primers 
with flanking NotI and AscI restriction enzyme sites to facilitate cloning. BSG-d0+1 and 
BSG-d1 C-terminal domain truncation boundary amino acid sequence = HGPP. BSG-d2 
was cloned into the same vector as PfRh5 to add an exogenous signal peptide required for 
protein secretion and encompassed the sequence between PPRV.. to ..RSHL. Glycosylation 
sites were removed in BSG by mutating codons encoding all three asparagines in 
glycosylation motifs to aspartic acid. To remove N-linked glycans from soluble recombinant 
BSG, 500 units of PNGaseF (New England Biolabs) were added to 10 μl of a spent tissue 
culture supernatant and incubated for 15 minutes at 37 °C. Sialic acid residues were 
removed by adding 1.6 milli-units of Vibrio cholerae neuraminidase (Sigma) to 10 μl of a 
spent tissue culture supernatant and incubated for 15 minutes at 37 °C.
Interaction screening by AVEXIS
For the AVEXIS assay, bait and prey protein preparations were normalised to activities that 
have been previously shown to detect transient interactions (monomeric half-lives less than 
0.1 second) with a low false positive rate11. Biotinylated baits dialysed against HBS were 
immobilised in the wells of a streptavidin-coated 96-well microtitre plate (NUNC). 
Normalised preys were added, incubated for 2 hours at room temperature, washed 3x HBS/
0.1% Tween-20, 1x HBS. 125 μg/ml of nitrocefin was added, and absorbance values 
measured at 485 nm on a Pherastar plus (BMG laboratories). Controls were essentially as 
described12 and included: the Cd4d3+4 tag alone as a negative control bait, a biotinylated 
anti-Cd4 (anti-prey) antibody as a prey capture positive control. A positive control 
interaction consisting of the rat Cd200 bait detected using the rat Cd200R prey used at the 
threshold level and both 1:10 and 1:100 dilutions was included on each plate. The negative 
(−) and positive (+) control interactions shown in Figure 1a are the rat Cd200R prey used at 
the screening threshold probed against the Cd4d3+4 (−) or rat Cd200 (+) baits.
P. falciparum culture, characterisation and invasion assays
All P. falciparum parasite strains were routinely cultured in human O+ erythrocytes at 5% 
hematocrit in complete medium (RPMI-1640 containing 10% human serum), under an 
atmosphere of 1% O2, 3% CO2, and 96% N2. To confirm their identity, laboratory-adapted 
strains were genotyped by PCR within polymorphic regions of the msp1 and msp2 genes30. 
Parasite cultures were synchronized in early stages with 5% (w/v) D-sorbitol (Sigma). Use 
of erythrocytes from human donors for P. falciparum culture was approved by the NHS 
Cambridgeshire 4 Research Ethics Committee. Ok(a−) blood was obtained from donors in 
Japan with informed consent, and shipped on ice. For each sample, a control Ok(a+) sample 
was collected at the same time under identical conditions. All experiments were performed 
within 72 hours of collection.
Crosnier et al. Page 6













Invasion assays were carried out in round-bottom 96-well plates, with a culture volume of 
100 μL per well at a hematocrit of 2%. Parasites in trophozoite stage were mixed with 
pentamerized BSG-S-Cd4d3+4-COMP-His ectodomains or with anti-BSG monoclonal 
antibodies and incubated in the plates for 24 hours at 37 °C inside a static incubator culture 
chamber (VWR), gassed with 1% O2, 3% CO2, and 96% N2. At the end of the incubation 
period, red blood cells (RBC) were harvested and parasitized RBC (pRBC) were stained 
with 2 μM Hoechst 33342 (Invitrogen), as described previously21. Invasion assays using 
Ok(a−) blood and control Ok(a+) blood were carried out following the two-colour flow 
cytometric assay described in21. Briefly, Ok(a−) blood and control Ok(a+) blood were 
labelled with 10 μM DDAO-SE (Invitrogen). RBC were resuspended to 2% hematocrit, 
mixed with pRBC (ring stage) and incubated in 96-well plates for 48 hours as described 
above. At the end of the incubation period, RBC were harvested and pRBC were stained 
with 2 μM Hoechst 33342. Standard blood smear microscopy was performed to determine 
parasitemia. Briefly, a small aliquot of the culture was smeared on a glass slide, fixed with 
100% methanol and stained with Field’s Stain (Pro-Lab Diagnostics). Parasitemia was 
determined by counting the number of parasitized red blood cells (pRBC) per 2,000 total red 
blood cells (RBC) examined by oil immersion with a Leica DME microscope (Leica 
Microsystems). All parasitemia represented were the average of three replicates. Lentiviral-
delivered shRNA sequences were: BSG; TRC clone ID (TRCN0000006736) hairpin 
sequence: 
GAAGTCGTCAGAACACATCAACTCGAGTTGATGTGTTCTGACGACTTC, pLKO 
scrambled control; (Addgene plasmid 1864) hairpin sequence: 
CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG; loop 
region indicated in bold. Detailed Standard Operating Procedures for all invasion assays are 
available at http://www.sanger.ac.uk/research/
Flow cytometry
Stained samples were examined with a 355 nm UV laser (20 mW) and a 633 nm red laser 
(17 mW) on a BD LSRII flow cytometer (BD Biosciences). Hoechst 33342 (Invitrogen) was 
excited using the UV laser and detected with a 450/50 filter, while DDAO-SE (Invitrogen) 
was excited using the red laser and detected with a 660/20 filter. BD FACS Diva (BD 
Biosciences) was used to collect 100,000 events for each sample. FSC and SSC voltages of 
423 and 198, respectively, and a threshold of 2,000 on FSC were applied to gate the 
erythrocyte population. The data collected were further analyzed with FlowJo (Tree Star). 
All experiments were carried out in triplicate. GraphPad Prism (GraphPad Software) was 
used to plot the generated parasitemia data.
PfRh5 cloning and sequencing
Total RNA was extracted from 3D7 and FCR3 schizonts using the QIAamp RNA Blood 
Mini Kit (Qiagen). Isolated RNA was treated with TURBO™ DNase (Ambion) and reverse 
transcribed to cDNA using the High-Capacity™ cDNA Archive Kit (Applied Biosystems) 
following the manufacturer’s instructions. A 10 μl aliquot of cDNA was used as a template 
in a standard PCR reaction, using the primers Rh5-F (5′-
ATGATAAGAATAAAAAAAAAATTAATTTTGACCATT-3′) and Rh5-R (5′-
TCATTGTGTAAGTGGTTTATTTTTTTTATATGTTTG-3′). Amplified fragments were 
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subcloned into pCR2.1-TOPO, using the TOPO TA Cloning Kit (Invitrogen) and three 
clones from each strain were sequenced and analysed.
Antibodies
Antibodies were obtained from the following suppliers: anti-rat Cd4d3+4 (OX68) (AbD 
Serotec), anti-CD59 (AbD Serotec), mouse IgG1 control (Abcam). Anti-BSG monoclonal 
antibodies used were: 8J251 (Lifespan Biosciences), MEM-M6/1 (Abcam) and TRA-1-85 
(R&D systems). MEM-M6/6 was provided as an ascitic fluid and was a generous gift of 
Professor Vaclav Horejsi (Institute of Molecular Genetics, Czech Republic); the antibody 
was purified using a HiTrap protein G column (GE Healthcare) as described31 and 
exchanged into RPMI.
Surface plasmon resonance
Surface plasmon resonance studies were performed using a Biacore T100 instrument. 
Briefly, biotinylated bait proteins were captured on a streptavidin-coated sensor chip 
(Biacore, GE Healthcare). Approximately 150RU of the negative control bait (biotinylated 
rat Cd4d3+4) were immobilised in the flow cell used as a reference and approximate molar 
equivalents of the query protein immobilised in other flow cells. Purified analyte proteins 
were separated by gel filtration just prior to use in SPR experiments to remove small 
amounts of protein aggregates which are known to influence kinetic binding 
measurements32. Increasing concentrations of purified proteins were injected at high flow 
rates (100 μl/min) to minimise rebinding effects for kinetic studies or at 10 μl/min for 
equilibrium analysis. Although essentially all the bound PfRh5 dissociated during the wash 
out phase (see Fig. 1c), the surface was “regenerated” with a pulse of 2M NaCl at the end of 
each cycle. Duplicate injections of the same concentration in each experiment were 
superimposable demonstrating no loss of activity after regenerating the surface. Both kinetic 
and equilibrium binding data were analysed in the manufacturer’s Biacore T100 evaluation 
software (Biacore). Equilibrium binding measurements were taken once equilibrium had 
been reached using reference-subtracted sensorgrams. Both the kinetic and equilibrium 
binding studies involving BSG-S and variants were performed three times using independent 
protein preparations of both PfRh5 and the BSG proteins, and once for BSG-L and its 
variants. All experiments were performed at 37 °C.
Enzyme-linked immunosorbant assay (ELISA)
Biotinylated ectodomains were immobilized on streptavidin-coated plates (Nunc) for one 
hour before being incubated for 90 minutes with 10 μg/ml primary antibody. The plates were 
washed in HBS/0.1% Tween-20 (HBST) before incubation with an appropriate secondary 
antibody conjugated to alkaline phosphatase (Sigma). Plates were washed 3x HBST and 1x 
HBS before adding 100 μl p-nitrophenyl phosphate (Sigma 104 alkaline phosphatase 
substrate) at 1 mg/ml. Optical density measurements were taken at 405 nm on a Pherastar 
plus (BMG laboratories). The whole procedure was performed at room temperature.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. BSG is an erythrocyte receptor for PfRh5
(a) PfRh5 was screened as either a prey (top panel) or a bait (bottom panel) against an 
erythrocyte receptor protein library using AVEXIS. BSG (protein 9) was identified as a 
receptor for PfRh5 in both bait-prey orientations. (b) Domain structure of the BSG isoforms 
(left); lollipops represent potential N-linked glycosylation sites. BSG regions were expressed 
as baits and used to map the PfRh5 binding site to the two membrane-proximal domains. 
Bar charts show mean ± SEM; n = 3. (c) Biophysical analysis of the PfRh5-BSG-S 
interaction using SPR. The indicated concentrations of purified PfRh5 were injected over 
immobilised BSG, and biophysical parameters derived from a 1:1 binding model (red line).
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Figure 2. Soluble BSG, anti-BSG antibodies and BSG knockdown potently block erythrocyte 
invasion
(a) Erythrocyte invasion was inhibited by purified pentamerised BSG-S-Cd4d3+4-COMP-
His ectodomains but not by the two non-binding BSG-S domains added individually or 
Cd4d3+4-COMP-His (control); strain = Dd2. (b) Cross-strain inhibition of invasion using 
pentamerised BSG-S. (c) Anti-BSG monoclonal antibodies, TRA-1-85 and MEM-M6/6, 
potently inhibited invasion of erythrocytes; strain = 3D7. (d) MEM-M6/6 concentrations 
≥10 μg/ml prevented all detectable invasion by microscopic observation of cultures; strain = 
3D7. (e, f) MEM-M6/6 inhibited invasion of synchronised P. falciparum culture-adapted 
lines (e) and unsynchronised field isolates (f). (g) Cell surface BSG is reduced in 
erythrocytes differentiated from hematopoietic stem cells transduced with lentiviruses 
containing shRNA targeting BSG (light blue line) relative to a control virus (pLKO, shaded); 
black line represents secondary antibody alone. (h) 3D7 and W2mef invasion was inhibited 
in BSG knockdown erythrocytes. A and B are replicates. Invasion efficiencies are mean ± 
SEM, n = 3.
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Figure 3. The Ok(a−) BSG variant has reduced binding affinity for PfRh5 and Ok(a−) 
erythrocytes have reduced merozoite invasion frequencies
(a) Schematic of the membrane distal IgSF domain of BSG-S showing the location of 
naturally-occurring variants. (b) Equilibrium binding isotherms of PfRh5 binding to BSG-S 
variants. (c) Association (ka) and dissociation (kd) rate constants of PfRh5 binding to BSG-S 
and variants. Means ± SEM; n = 3. (d) Invasion of 3D7 and Dd2 strains in Ok(a−) blood 
cells are reduced relative to the Ok(a+) control. Mean ± SEM, n = 3; *, P ≤ 0.0003; #, P = 
0.0349, unpaired one-tailed t test. A repeat is shown in Supplementary Fig. 9.
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